A61K 38/34
Melanocyte stimulating hormone [msh]
Official title: Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
A61K38/34 (Melanocyte stimulating hormone [msh]) appears on 108 US grants and 178 published applications in this corpus.
Search patents in A61K- Granted patents
- 108
- Published applications
- 178
- Assignees
- 75
- Inventors
- 247
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 6 |
| 2003 | 0 | 8 |
| 2004 | 3 | 7 |
| 2005 | 5 | 9 |
| 2006 | 1 | 10 |
| 2007 | 4 | 3 |
| 2008 | 2 | 6 |
| 2009 | 1 | 10 |
| 2010 | 4 | 6 |
| 2011 | 1 | 6 |
| 2012 | 3 | 5 |
| 2013 | 5 | 9 |
| 2014 | 5 | 15 |
| 2015 | 2 | 10 |
| 2016 | 13 | 14 |
| 2017 | 14 | 12 |
| 2018 | 9 | 8 |
| 2019 | 8 | 5 |
| 2020 | 4 | 6 |
| 2021 | 3 | 6 |
| 2022 | 4 | 5 |
| 2023 | 3 | 6 |
| 2024 | 2 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of administering chimeric antigen receptor immunotherapy18 Aug 2026US 12,709,639 B2Kite Pharma, Inc.
- Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages20 May 2025US 12,303,555 B2Nanyang Technological University
- Use of bremelanotide in patients with controlled hypertension24 Dec 2024US 12,171,807 B2Cosette Pharmaceuticals, Inc.
- Melanocortin 1 receptor ligands and methods of use24 Dec 2024US 12,173,087 B2Arizona Board of Regents on Behalf of the University of Arizona
- Bovine adrenal medulla peptide 8-22 compounds and methods of use thereof for treating pain8 Aug 2023US 11,718,646 B2Trustees of Tufts College
- Murine stem cell factor polypeptides, compositions, and methods of use10 Sep 2026US 2026/0263610 A1Elixr Ltd
- Compositions for the treatment of disease4 Jun 2026US 2026/0151434 A1SightStream Biotherapeutics, Inc.
- Methods of stimulating appetite and/or increasing body weight using non-naturally occurring melanocortin receptor antagonist analogs9 Apr 2026US 2026/0098072 A1Endevica Bio, Inc.
- Melanocortin 1 receptor ligands and methods of use24 Apr 2025US 2025/0129118 A1Arizona Board of Regents on Behalf of the University of Arizona
- Uses of bremelanotide in therapy for female sexual dysfunction10 Oct 2024US 2024/0335502 A1Cosette Pharmaceuticals, Inc.
Most cited
By later US patents
- Stimulation of tear secretion with melanocyte stimulating hormones75US 4,868,154 AEye Research Institute of Retina Foundation · 1989
- Method of stimulating integumental melanocytes by topical application of analogs of alpha-msh74US 4,866,038 AUniversity Patents, Inc. · 1989
- Topical systems and methods for treating sexual dysfunction42US 9,241,899 B2Transdermal Biotechnology, Inc. · 2016
- Systems and methods for delivery of peptides41US 9,295,647 B2Transdermal Biotechnology, Inc. · 2016
- Methods and systems for treating or preventing cancer41US 9,314,433 B2Transdermal Biotechnology, Inc. · 2016